Completed NA INTERVENTIONAL NCT01522209

Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging (CEIOUS-Liver)

Value of Contrast Enhanced Intraoperative Ultrasound Compared to Preoperative CEUS, CT and MRT in the Treatment of Colorectal Liver Metastases.

Sponsor: Asklepios Kliniken Hamburg GmbH

Conditions Colon Cancer Liver Metastasis Contrast Enhances Intraoperative Ultrasound Imaging for Liver Cancer Imaging for Liver Metastasis

Interventions CT Scan (standard) Contrast Enhanced Ultrasound Liver Surgery Primovist MRI (3 Tesla)

Updated 5 times since 2017 Last updated: Jan 14, 2015 Started: Dec 31, 2011 Primary completion: Dec 31, 2014 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Colon Cancer Liver Metastasis and Contrast Enhances Intraoperative Ultrasound and is currently completed. Asklepios Kliniken Hamburg GmbH leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asklepios Kliniken Hamburg GmbH

Data source: Asklepios Kliniken Hamburg GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany